These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1678527)

  • 1. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys.
    Lawrence MS; Redmond DE
    Pharmacol Biochem Behav; 1991 Apr; 38(4):869-74. PubMed ID: 1678527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey.
    Elsworth JD; Lawrence MS; Roth RH; Taylor JR; Mailman RB; Nichols DE; Lewis MH; Redmond DE
    J Pharmacol Exp Ther; 1991 Nov; 259(2):595-600. PubMed ID: 1682479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys.
    Taylor JR; Elsworth JD; Lawrence MS; Sladek JR; Roth RH; Redmond DE
    Exp Neurol; 1999 Jul; 158(1):214-20. PubMed ID: 10448434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys.
    Gomez-Mancilla B; Bédard PJ
    Exp Neurol; 1992 Aug; 117(2):185-8. PubMed ID: 1354166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.
    Akai T; Yamaguchi M; Mizuta E; Kuno S
    Ann Neurol; 1993 May; 33(5):507-11. PubMed ID: 8098931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism.
    Graham WC; Sambrook MA; Crossman AR
    Brain Res; 1993 Feb; 602(2):290-303. PubMed ID: 8095431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys.
    Lawrence MS; Redmond DE; Elsworth JD; Taylor JR; Roth RH
    Life Sci; 1991; 49(25):PL229-34. PubMed ID: 1836030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.
    Luquin MR; Guillén J; Martínez-Vila E; Laguna J; Martínez-Lage JM
    Eur J Pharmacol; 1994 Mar; 253(3):215-24. PubMed ID: 7911084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous eye-blink rates and dopaminergic systems.
    Karson CN
    Brain; 1983 Sep; 106 (Pt 3)():643-53. PubMed ID: 6640274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease.
    Pifl C; Nanoff C; Schingnitz G; Schütz W; Hornykiewicz O
    J Neurochem; 1992 Jun; 58(6):1997-2004. PubMed ID: 1349341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW
    Fortschr Neurol Psychiatr; 1989 Apr; 57(4):142-8. PubMed ID: 2656447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis).
    Graham WC; Clarke CE; Boyce S; Sambrook MA; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):103-10. PubMed ID: 2192772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P
    Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of D1 receptor stimulation in normal and MPTP monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1989 Sep; 104(1-2):223-8. PubMed ID: 2573015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug effect on blink rates in rhesus monkeys: preliminary studies.
    Karson CN; Staub RA; Kleinman JE; Wyatt RJ
    Biol Psychiatry; 1981 Mar; 16(3):249-54. PubMed ID: 7225488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the basal ganglia in nicotinic modulation of the blink reflex.
    Evinger C; Basso MA; Manning KA; Sibony PA; Pellegrini JJ; Horn AK
    Exp Brain Res; 1993; 92(3):507-15. PubMed ID: 8454014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.